| Leishen Energy Reaffirms Middle East Market Commitment; Saudi Production Facility Progressing Amid Regional Challenges |
Globe Newswire |
04/13 |
06:00 |
| ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device |
Globe Newswire |
04/13 |
06:00 |
| Vitaquest Fall 2026 Dietary Supplement Trends Report: Key Insights for Brands and Manufacturers |
Globe Newswire |
04/13 |
06:00 |
| K92 Mining Announces Strong Q1 Production Results – 46,743 oz AuEq Produced, in Line With Budget, With Record Lateral Development Now Exceeding Stage 3 Expansion Requirements |
Globe Newswire |
04/13 |
06:00 |
| Springboards Launches ‘Flint’ to Break AI’s Habit of Predictable, Boring Answers |
Globe Newswire |
04/13 |
06:00 |
| MEDP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit |
Globe Newswire |
04/13 |
05:59 |
| Nordic American Tankers Ltd (NYSE: NAT) – Chaotic conditions create more transportation work for NAT |
Globe Newswire |
04/13 |
05:38 |
| Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows |
Globe Newswire |
04/13 |
03:51 |
| Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada |
Globe Newswire |
04/13 |
03:20 |
| Baker Hughes Announces Sale of Waygate Technologies to Hexagon |
Globe Newswire |
04/13 |
02:00 |
| Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer |
Globe Newswire |
04/13 |
02:00 |
| SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT) |
Globe Newswire |
04/13 |
02:00 |
| WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026 |
Globe Newswire |
04/13 |
01:00 |
| Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria |
Globe Newswire |
04/13 |
01:00 |
| Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE) |
Globe Newswire |
04/13 |
01:00 |
| Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU) |
Globe Newswire |
04/13 |
01:00 |
| New Crypto Pepeto DeFi Exchange Update While Dogecoin Price Holds at $0.09 and Shiba Inu Eyes Recovery |
Globe Newswire |
04/12 |
22:24 |
| ROSEN, LEADING TRIAL ATTORNEYS, Encourages Power Solutions International, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PSIX |
Globe Newswire |
04/12 |
22:10 |
| Bitcoin Poker No Deposit Bonus 2026: BC Poker Offers $10 Free to Play Online Poker for Real Money With No Cashout Cap, Provably Fair Tables, and Instant Crypto Withdrawals |
Globe Newswire |
04/12 |
22:00 |
| ROSEN, A LEADING AND RANKED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR |
Globe Newswire |
04/12 |
21:01 |
| ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages monday.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MNDY |
Globe Newswire |
04/12 |
20:53 |
| Rubicon Organics Launches 1964 Supply Co.™ in the U.K. |
Globe Newswire |
04/12 |
20:00 |
| Crypto News: Pepeto Announces Investments Growth While Bitcoin Price Prediction Moves After Iran Talks Collapse |
Globe Newswire |
04/12 |
19:43 |
| Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia |
Globe Newswire |
04/12 |
19:30 |
| APO DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Apollo Global Management, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - APO |
Globe Newswire |
04/12 |
19:16 |
